About Stynus Pharmaceuticals Private Limited
Data last updated:
Stynus Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 June 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24299KA2018PTC114268. Its GSTIN is 29ABACS5065M1ZU (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Penchala Narsimha Prasad Maddisetty and Sunitha Thomdam.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at No: 1197/1 4th Floor 16th A Main Road 22nd Cross Road Sector 3 Hsr Layout, Bangalore, Karnataka, India – 560102.
As per the financials filed for FY 2023, the company reported a revenue of ₹7.93 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹4.33 Lakh (net margin -54.6%) and EBITDA of -₹4.18 Lakh (EBITDA margin -52.6%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years.
The company is associated with 1 brand: Stynus.
For more details, the company can be reached via its website stynus.com.
Company details
Contact details
Stynus Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its website is stynus.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo: 1197/1 4th Floor 16th A Main Road 22nd Cross Road Sector 3 Hsr Layout, Bangalore, Karnataka, India – 560102
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Stynus Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Stynus Pharmaceuticals operates one associated brand: Stynus. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceuticals, herbal, food, FMCG, and dietary supplements for health and consumer needs. | stynus.com |
Business activity
The main business activity of Stynus Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Stynus Pharmaceuticals Private Limited, buy the company report.
Financials of Stynus Pharmaceuticals Private Limited
FY 2023 filings availableStynus Pharmaceuticals Private Limited reported revenue of ₹7.93 Lakh (up 152% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 25% over three years, including 152% growth in the latest year. EBITDA rose 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.18 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.33 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -52.6% | ||||
| Net Profit Margin | -54.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Stynus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Stynus Pharmaceuticals Private Limited
Stynus Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Penchala Narsimha Prasad Maddisetty Also directs: Bionus Private Limited, Vivitaz Healthcare Private Limited | Director | 26 Jun 2018 | 8 Years 3 Months | Current |
| Sunitha Thomdam Also directs: Bionus Private Limited | Director | 26 Jun 2018 | 8 Years 3 Months | Current |
Auditor
Stynus Pharmaceuticals Private Limited is audited by CHARLES & CHANDRASEKAR for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CHARLES & CHANDRASEKAR | FY 2022 | 005759S |
Shareholding
The shareholding of Stynus Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Stynus Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Stynus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Stynus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Stynus Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29ABACS5065M1ZU | Karnataka | Active | 24 Aug 2018 |
To see the full GST registrations and return filing status of Stynus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Stynus Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Penchala Narsimha Prasad Maddisetty was appointed as Director on 26 Jun 2018.
Frequently asked questions
Stynus Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 June 2018 (8+ years old) and is registered under CIN U24299KA2018PTC114268.
Stynus Pharmaceuticals has 2 current directors:
- Penchala Narsimha Prasad Maddisetty - Director
- Sunitha Thomdam - Director
The latest financial statements of Stynus Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Stynus Pharmaceuticals is 29ABACS5065M1ZU, registered in Karnataka.
The CIN (Corporate Identification Number) of Stynus Pharmaceuticals is U24299KA2018PTC114268. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stynus Pharmaceuticals was incorporated on 26 June 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.
Penchala Narsimha Prasad Maddisetty was appointed as Director on 26 Jun 2018. Sunitha Thomdam was appointed as Director on 26 Jun 2018.
Stynus Pharmaceuticals can be reached through the website stynus.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Stynus Pharmaceuticals is at No: 11971 4th Floor 16th A Main Road 22nd Cross Road Sector 3 Hsr Layout, Bangalore, Karnataka, India – 560102.
Stynus Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.